Common Contracts
2 similar Equity Interest Purchase Agreement contracts by Cerecor Inc.
EX-2.1 2 a17-27312_1ex2d1.htm EX-2.1 EXECUTION VERSION EQUITY INTEREST PURCHASE AGREEMENT by and among CERECOR INC., TRx PHARMACEUTICALS, LLC, THE SELLERS NAMED HEREIN and RANDAL JONES AND ROBERT MOSCATO (SOLELY FOR PURPOSES OF SECTION 6.2 HEREOF)...Equity Interest Purchase Agreement • May 5th, 2020 • North Carolina
This EQUITY INTEREST PURCHASE AGREEMENT, dated as of November 17, 2017 (the “Agreement”), is by and among Cerecor Inc., a Delaware corporation (“Purchaser”), TRx Pharmaceuticals, LLC, a North Carolina limited liability company (the “Company”), the members of the Company listed on the signature pages hereof (each a “Seller” and collectively, the “Sellers”), and, solely for purposes of Section 6.2 hereof, Randal Jones and Robert Moscato (the “Owners” and, together with the Sellers, the “Restricted Parties”).
EQUITY INTEREST PURCHASE AGREEMENT by and among CERECOR INC., TRx PHARMACEUTICALS, LLC, THE SELLERS NAMED HEREIN and RANDAL JONES AND ROBERT MOSCATO (SOLELY FOR PURPOSES OF SECTION 6.2 HEREOF)Equity Interest Purchase Agreement • November 17th, 2017 • Cerecor Inc. • Pharmaceutical preparations • North Carolina
This EQUITY INTEREST PURCHASE AGREEMENT, dated as of November 17, 2017 (the “Agreement”), is by and among Cerecor Inc., a Delaware corporation (“Purchaser”), TRx Pharmaceuticals, LLC, a North Carolina limited liability company (the “Company”), the members of the Company listed on the signature pages hereof (each a “Seller” and collectively, the “Sellers”), and, solely for purposes of Section 6.2 hereof, Randal Jones and Robert Moscato (the “Owners” and, together with the Sellers, the “Restricted Parties”).
